King Edward VII Hospital launches low-dose breast cancer scan

London: The King Edward VII hospital has become the first private medical centre to offer patient’s state-of-the-art low dose radiation digital mammography for the detection of breast cancer.

The Swedish-made Sectra scanner allowed the highest resolution breast scan at the lowest dose or radiation, compared to any other system currently in use.

The Sectra Microdose Digital X-ray system uses a digital capturing system which also means very high resolution images (24.96 megapixels) which can detect the smallest micro-calcifications in the breast. The radiation dose which the patient receives during the scan is 20% of that emmited by conventional machines.

The Sectra has already been subjected to a three-year clinical trial within the NHS, at the Coventry Breast Screening Unit at the Coventry and Warwick Hospital

According to doctors the benefits of even a conventional mammogramme outweigh the risks in detection of breast cancer. Women over the age of 50 are advised to have a scan every three years.

In the UK, experts estimate that 1 in every 14,000 women may suffer radiation induced breast cancer – that is approximately eight women each year.

But the low dose Sectra machine means that women can have more frequent scans so that any disease can be caught at an earlier stage.

The hospital’s Imaging Department is also able to give patients a copy of their scan on a CD after their mammogram.

For further information go to www.kingedwardvii and more detailed information on the Sectra at

Stylish tester for use by diabetics goes on sale


LifeScan is tackling the social stigma of blood testing for people with diabetes. Recent research* by the company found that a third of all British people with diabetes fail to regularly test themselves, particularly when out and about in public. This is in part because of the embarrassment at using existing monitoring devices, which are conspicuously clinical in appearance.

Many patients refer to the chore of daily blood testing and the embarrassment of devices that draw attention to the fact that they have a health problem as reasons for skipping regular testing, the consequences of which will inevitably be an increase in serious diabetes-related health problems.

To counter this worrying trend, Johnson & Johnson’s LifeScan has created a monitoring device more suited to modern life. OneTouch UltraEasy Colours is much smaller in size and comes in a selection of colours, just like iPods and MP3 players, to help overcome the stigma associated with diabetes and ensure patients feel more comfortable when testing. In colour creative tests conducted in June 2007 for LifeScan with 151 diabetics in the UK by Decision Analyst, more than one in five patients said they would be more inclined to use the OneTouch UltraEasy Colours product as its compact size and sleek non-clinical design offer a more discreet blood testing system that makes regular monitoring feel less daunting.

From today, OneTouch UltraEasy Colours will be available exclusively in over 1,300 Lloyds pharmacies across the UK for one month before becoming available in other retailers.The devices will also soon be available online at

To find a pharmacy go to

Olivier Lechanoine, Marketing Director for LifeScan UK & Ireland , says, “With the OneTouch UltraEasy Colours product, we want to help take the anxiety out of diabetes testing. Not only does the discreet OneTouch LifeScan meter give a simple and accurate reading in just five seconds, but its size and design make it look nothing like the clinical devices you would normally associate with blood glucose testing.”

Diabetes in the UK

The UK has one of the fastest growing rates of diabetes in the developed world, with 3.93% of the population (almost 2.4 million Britons) suffering from diabetes.

At present there are 1.78 million meter users in the UK who collectively have to perform an estimated 810 million vital blood tests per year. However, research by LifeScan reveals that diabetes patients are becoming more and more complacent when it comes to proactive engagement in managing their diabetes.

Worryingly, over a third of diabetes patients do not test as often as recommended by their doctor or health care advisor, largely because of the lifestyles they lead. Whether it is forgetfulness (60%), frustration and inconvenience at having to test (28% respectively), or simply being too busy (22%); hundreds of thousands of patients are putting their lives at risk by neglecting to test at the recommended times.

New OneTouch UltraEasy Colours are available in pink, green and red/black. They are priced at £12.99 excl VAT.